Charged Alpha Stock Encyclopedia

Charged Alpha Stock Encyclopedia

By Colton ThomasBusinessInvesting
Download on the App Store

Charged Alpha Stock Encyclopedia episodes

  • BIDU Stock Q2 2026: Baidu - The AI Engine Went Backwards, Not The Ads
    Baidu (BIDU) Q2 2026 — Baidu released Q2 2026 results before the US open on Tuesday August 18, so August 18 was itself the reaction session. The shares closed at USD104.12 on August 17, OPENED at USD94.35 - a 9.4 pct gap down - traded as low as USD89.60 and closed at USD90.87, down 12.73 pct, on 16.1M shares against a 2.0M twenty-session average. That is 8.1x normal volume, and the heaviest session on the twelve-month chart.
    Baidu is the Chinese search and AI company behind Baidu App, which reached 644M monthly users in June, plus ERNIE, AI Cloud and the Apollo Go robotaxi fleet now running in 28 cities. Q2 2026 revenue was RMB31.3bn, about USD4.62bn, down 4 pct on the year. Non-GAAP earnings came in at USD1.06 per ADS against a USD1.51 bar, and the shares fell 12.73 pct on the print.
    THE CALL: HOLD (3/5, MEDIUM - THE BALANCE SHEET IS THE FLOOR, THE CASH FLOW IS THE PROBLEM) — base-case value ~$106.12 vs ~$90.87 today.
    KEY METRICS:
    - CALL: HOLD, 3/5. Fair value USD106.12 against the USD90.87 close, +16.8 pct. Bear USD81.29 / base USD105.06 / bull USD140.07. The balance sheet caps the downside; the cash-flow statement is why we will not pay up for the option yet.
    - THE ANGLE: AI Cloud Infra revenue fell 17 pct SEQUENTIALLY, from RMB8.8bn to RMB7.3bn, in the same quarter management described its growth as accelerating. The growth engine went backwards, and that is what actually repriced the stock.
    - AND THE ADS DID NOT: online marketing revenue ROSE 4.0 pct sequentially, RMB12.6bn to RMB13.1bn, its first sequential increase in the disclosed series. Search advertising stabilised over ninety days while the AI line shrank.
    - THE EPS MISS IS A DECOY: non-GAAP OPERATING income was RMB3,785M against RMB3,807M last quarter, down 0.6 pct. The entire 40 pct fall in non-GAAP earnings per ADS happened below the operating line, not inside the business.
    - WHAT ACTUALLY HIT EPS: a foreign exchange loss of RMB1,160M, interest income down RMB278M, equity-method earnings down RMB179M, and an effective tax rate that jumped from 13.8 pct to 31.2 pct in a single quarter.
    - THE EPS BASIS, PROVEN: the USD1.06 the data vendors carry is non-GAAP DILUTED EPS PER ADS. RMB7.22 divided by the RMB6.7851 rate is USD1.06, and Q1 plus Q2 equals the printed six-month figure exactly. The miss is real, not an artefact.
    - THE SPEND: capital expenditure tripled year over year to RMB11,390M and free cash flow was MINUS RMB7,954M. Baidu added RMB17.4bn of long-term loans since December to fund a build whose revenue has just fallen sequentially.
    What to watch: UP: one quarter of AI Cloud Infra revenue back above the RMB8.8bn March level, which would kill the lumpiness argument outright; a materially larger buyback against the USD31.3bn market value; or the Hong Kong dual-primary conversion widening the onshore shareholder base. DOWN: capital spending holding near RMB11.4bn a quarter without the cloud revenue following it, compounding a free cash burn that is already 19 pct of net liquid assets a year.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    15 min
  • ANDG Stock Q2 2026: Andersen Group - Record Revenue, And The 12% You Actually Own
    Andersen Group (ANDG) Q2 2026 — Andersen released after the close on Wednesday August 12 and held its call at 5:00pm ET, so Thursday August 13 was the reaction session. The shares OPENED at USD45.37 against a USD50.00 prior close - down 9.26 pct - traded as low as USD44.11 (-11.78 pct), then were bought back all session to close USD48.30, only 3.40 pct lower, on 854,720 shares (2.4x the 20-session average). By August 17 they were USD49.00.
    Andersen Group is the San Francisco tax, valuation and legal advisory firm that IPO'd on December 17 2025 - 2,690 people, 28 offices, 13,500 client groups. Q2 revenue was USD217.7M, up 23.7 pct, with adjusted net income of USD39.0M up 38.8 pct and a 21.1 pct adjusted EBITDA margin. It also reported a USD10.1M GAAP net loss and a USD0.09 diluted loss per Class A share.
    THE CALL: AVOID (3/5, MEDIUM - THE BUSINESS IS GOOD, THE PRICE AND THE STRUCTURE ARE NOT) — base-case value ~$37.26 vs ~$49.00 today.
    KEY METRICS:
    - CALL: AVOID, 3/5. Fair value USD37.26 against the USD49.00 close, -24.0 pct. Bear USD24.27 / base USD37.21 / bull USD50.36, weighted 25/50/25 on 2027 adjusted EBITDA less the USD30.1M of equity pay that recurs.
    - THE ANGLE: the growth is real and organic, but Class A owns 12.0 pct of it. 13.6M Class A shares against 99.4M Class B, which carry ten votes each and NO economic rights. One holder keeps 98.1 pct of the vote.
    - THE GROWTH IS NOT BOUGHT: acquisitions contributed USD5.5M of the USD41.7M revenue increase, so organic growth was 20.6 pct and accelerated from 15.7 pct in Q1. All four service lines grew; no one-time items.
    - THE EPS BASIS: the data vendors carried USD0.34; the income statement prints USD(0.08) basic and USD(0.09) diluted on 13,261,049 weighted-average Class A shares. USD0.34 is adjusted net income over all 113.0M units and appears nowhere in the filing.
    - THE ADD-BACK: USD48.3M of non-cash equity pay, 22.2 pct of revenue. USD42.3M is the December reorganisation vest and does run off; USD6.0M is LTIPs, RSUs and stock issued to acquired firms - all three were ZERO a year ago.
    - THE CASH: six-month operating cash flow was USD65.8M (up 6.4 pct on revenue up 19.4 pct) and free cash flow USD52.7M, half the USD106.3M of adjusted net income. USD132.5M went out to the pre-IPO owners in distributions and note repayments.
    - THE GUIDE: revenue reaffirmed at USD980M-USD1,000M (about 18 pct growth) but adjusted EBITDA at USD225M-USD250M, a 23-25 pct margin against 27.1 pct actually delivered in 2025. And on August 17 insiders registered 4,284,457 Class A shares for sale.
    What to watch: UP: a full-year adjusted EBITDA guide raised above USD250M while revenue growth holds in the high teens; receivables growing slower than revenue so free cash flow converges on adjusted profit; or a Q3 print (the seasonally large one) that beats the margin guide. DOWN: the August 17 secondary pricing below USD49.00; receivables above USD189.4M again; or adjusted EBITDA margin landing at the 23 pct bottom of the guide against 27.1 pct delivered in 2025.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    15 min
  • OCTV Stock Q2 2026: Octave Intelligence - The $2.1B Write-Down Its Own Stock Caused
    Octave Intelligence plc (OCTV) Q2 2026 — Octave issued the release at 13:00 CEST (07:00am ET) on Wednesday August 12 and held the call at 8:00am ET, so August 12 was the reaction session. The shares OPENED at USD16.66 against a USD19.72 prior close - down 15.5 pct and the low of the day - then were bought back all session to close USD19.08, only 3.25 pct lower, on 7,793,542 shares (6.9x the 20-session average). By August 17 they were USD18.02.
    Octave Intelligence is the industrial software business Hexagon AB spun off on May 22 2026 - design, build, operate and protect software for asset-intensive industries and the public sector, run from Madison, Alabama. Q2 revenue was USD398.4M, down 3.6 pct, with ARR of USD1,143M up 7 pct, free cash flow of USD93.5M up 7.6 pct, and adjusted EPS of USD0.36 against a USD0.30 bar. It also booked USD2,134.7M of non-cash impairment charges.
    THE CALL: HOLD (3/5, MEDIUM - THE ACCOUNTANTS, THE MARKET AND THE MODEL ALL AGREE) — base-case value ~$19.60 vs ~$18.02 today.
    KEY METRICS:
    - CALL: HOLD, 3/5. Fair value USD19.60 against the USD18.02 close, +8.8 pct. Bear USD16.22 / base USD19.39 / bull USD24.41, weighted 25/55/20 on FY27 free cash flow of USD345M discounted at 9.25 pct over five years, fading to 2.25 pct.
    - THE ANGLE: the write-down that the share price wrote. The 10-Q says the interim goodwill test was triggered because market capitalisation had fallen below carrying value - the accounting followed the tape, not the business.
    - THE CHARGE: USD2,134.7M total - USD1,671.0M of goodwill plus USD463.7M of trademarks, 5.4x a quarter of revenue. 100 pct NON-CASH, added straight back in the cash-flow statement. Goodwill fell USD6,221M to USD4,555M.
    - IT DID NOT CLOSE THE GAP: even after the charge, equity of USD5,080M sat USD704M ABOVE the June 30 market value of USD4,376M - the filing calls that a reasonable control premium. Book is USD18.92 a share; the stock is USD18.02.
    - THE EPS BASIS: GAAP EPS was USD(7.34); ADJUSTED EPS was USD0.36 against USD0.30 modelled, a 20 pct BEAT and FLAT on last year. Proved: H1 adjusted USD0.69 less Q2 USD0.36 = USD0.33, exactly the vendors' Q1 row.
    - WHAT ACTUALLY DETERIORATED: United States revenue fell 12.1 pct to USD151.2M, perpetual licences 23.3 pct and services 19.5 pct, and adjusted operating margin went 31 pct to 29 pct with Q3 guided to about 27 pct. SaaS grew 22.9 pct.
    - THE BALANCE SHEET: USD304.1M cash against USD646.0M of brand-new borrowings, drawn to fund a USD625.0M cash payment to Hexagon at the spin. Net debt USD341.9M against a 3.5x covenant. Tangible book value is MINUS USD636.9M.
    What to watch: UP: market capitalisation back above carrying value at September 30, which retires the impairment trigger; or the perpetual licence and services lines stabilising so reported growth converges on the 7 pct recurring rate. DOWN: a Q3 adjusted operating margin below the ~27 pct guide, another leg down in US revenue after the 12.1 pct fall, or a second goodwill test against the USD4,555M still carried.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    16 min
  • CLBT Stock Q2 2026: Cellebrite Earnings - $15M Of ARR, $1.1B Of Market Value
    Cellebrite DI Ltd (CLBT) Q2 2026 — Cellebrite is a foreign private issuer and files 6-K, not 8-K. The results 6-K cleared EDGAR at 11:15am ET on Thursday August 13 - BEFORE the open, so August 13 itself was the reaction session: the shares opened USD10.32 against a USD15.25 prior close, traded as low as USD9.58 and closed USD10.80. That is minus 29.18 pct on 36,750,400 shares, 30.9x the 20-session average. By August 17 they were USD10.44.
    Cellebrite DI is the Israeli digital-forensics company whose software is used by more than 7,000 law-enforcement, defence and intelligence agencies. Q2 revenue was USD131.138M, up 15.8 pct, with annual recurring revenue of USD507.8M, up 21 pct, non-GAAP gross margin of 85.5 pct and USD545.7M of net cash against no borrowings. The shares fell 29.18 pct on the print.
    THE CALL: HOLD (3/5, MEDIUM - THE CRASH REMOVED AN OVER-VALUATION, IT DID NOT CREATE ONE) — base-case value ~$9.44 vs ~$10.44 today.
    KEY METRICS:
    - CALL: HOLD, 3/5. Fair value USD9.44 against the USD10.44 close, minus 9.5 pct. Bear USD5.27 / base USD9.48 / bull USD13.53, weighted 25/50/25 on owner earnings of USD83.2M discounted over five years at 10 pct.
    - THE ANGLE: USD15M of ARR, USD1.1bn of market value. Cellebrite cut its full-year recurring-revenue target from a USD570M midpoint to USD555M. The equity lost USD1,125M the same session - about USD75 of market value per USD1 of ARR removed.
    - THE DECOMPOSITION: at the 5.81x forward ARR multiple the market paid on August 12, a USD15M cut is worth USD87M - 7.7 pct of the fall. The other USD1,038M, or 92.3 pct, is pure multiple compression: 5.81x down to 3.94x forward ARR.
    - THE EPS MISS DOES NOT EXIST: the Street bar is non-GAAP. Non-GAAP diluted EPS was USD0.11 against about USD0.07 modelled - a BEAT. Revenue of USD131.138M missed by 0.3 pct. Comparing GAAP USD0.0252 to that bar manufactures a fake miss.
    - WHAT ACTUALLY BROKE: ARR of USD507.8M missed Cellebrite's OWN May 14 guide of USD510-513M by 0.7 pct, and consensus of USD512.1M. Guided second-half net new ARR of USD47.2M is 23.7 pct below the USD61.9M added in the second half of 2025.
    - THE GAAP FALL IS NOT OPERATING: net income fell USD13.105M year on year - USD7.468M operating, USD2.136M lower interest income, USD3.501M tax. Last year's 6.3 pct effective tax rate was the anomaly against 43.0 pct now.
    - THE SOFT LINE IS CASH: quarterly free cash flow was USD14.521M against USD28.975M, a margin of 11.1 pct against 25.6 pct. The release leads with a trailing-twelve-month 28.0 pct instead. Backlog fell 8.7 pct since December to USD370.4M.
    What to watch: UP: third-quarter ARR printing at the top of the USD524-528M guide, which would weaken the deceleration case in a single quarter; or the equity-compensation run rate holding flat at USD61M while revenue compounds. DOWN: another sequential fall in remaining performance obligations after the 8.7 pct decline since December, or an ARR print starting with a four.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    13 min
  • SEPN Stock Q2 2026: Septerna Earnings - The Market Paid 23 pct For A Half-Life
    Septerna (SEPN) Q2 2026 — The 8-K cleared EDGAR at 4:03pm ET on August 10, AFTER the close, so Tuesday August 11 was the reaction session: the shares opened only +1.85 pct at USD39.57, traded as low as USD38.62, then were bought all day to close +22.93 pct at USD47.76 on 2.91x average volume. USD44.50 on August 14.
    Septerna is a clinical-stage biotechnology company developing oral small molecule drugs against G protein-coupled receptors, listed on the Nasdaq in October 2024. The June quarter beat on both lines: revenue USD26.7M against a USD19.2M bar, loss per share USD0.29 against USD0.426. But 54.6 pct of that revenue is amortisation of a Novo Nordisk upfront paid in July 2025, 41.9 pct is fully reimbursed research services, and only 3.4 pct is newly earned.
    THE CALL: AVOID (3/5, MEDIUM - THE MARKET PAID 23 PCT FOR A PHARMACOKINETIC PARAMETER) — base-case value ~$31.92 vs ~$44.50 today.
    KEY METRICS:
    - CALL: AVOID, 3/5. Fair value USD31.92 vs the USD44.50 close, -28.3 pct. Bear USD20.89 / base USD29.46 / bull USD42.31, weighted 50/25/25 across ONE model in which only the SEP-479 probability of success moves: 20 pct ours, 13 pct the industry base rate, 50 pct Stifel's own published figure.
    - THE PRINT: revenue USD26.7M vs USD19.2M expected, a 39.1 pct beat. Loss per share USD0.29 against a USD0.426 bar. R&D USD35.1M vs USD22.2M, G&A USD8.5M vs USD6.9M, operating loss USD16.8M. Net loss USD13.0M against USD24.8M a year earlier, helped by USD4.8M of interest income.
    - THE EPS BASIS, PROVEN: Q1 USD0.19 loss plus Q2 USD0.29 equals the filed six-month USD0.48 exactly, so the vendor epsActual series is GAAP. Basic and diluted are identical - 6,071,300 dilutive securities were anti-dilutive. FMP did NOT double-count the collaboration revenue.
    - THE REVENUE IS A SCHEDULE: Note 3 splits the USD26.7M three ways. USD14.6M is amortisation of Novo Nordisk's USD195.0M upfront, USD11.2M is research services Novo reimburses at 100 pct, USD0.9M is milestones. Only 3.4 pct is newly earned. USD140.4M of deferred revenue remains.
    - WHAT ACTUALLY MOVED IT: the observed elimination half-life of SEP-479 is approximately three to four days, which the company says supports once-daily oral dosing. The same release extended MAD dosing to 14 days and pushed Phase 1 SAD/MAD data to Q1 2027. SEP-631's planned Phase 2b in urticaria was dropped.
    - CASH IS NOT THE ISSUE: USD516.5M of cash, equivalents and marketable securities at June 30, plus USD33.7M net from the July ATM. Operating outflow USD22.2M in the quarter and USD47.8M in the half. No financial debt - the USD22.5M a screener shows is an operating lease. Runway guided at least into 2029.
    - THE STREET: 5 dated targets, all bullish, averaging USD50.60 (USD43-USD60). H.C. Wainwright USD60 Aug 12, Guggenheim USD51 Aug 11, Wells Fargo USD50 Aug 12, Stifel USD49 Aug 11, Truist USD43 Jul 1. We sit 36.9 pct below. The tape requires a 55.1 pct probability of success - above Stifel's 50 pct.
    What to watch: UP: a clean fourteen-day multiple-ascending-dose readout in Q1 2027 showing calcium control with no bilirubin signal, which lifts our 20 pct probability of success materially - every ten points is USD4.28 a share. Also a named, dated trial for SEP-631 in a mast-cell indication. DOWN: any unconjugated bilirubin signal in the extended cohorts, the event that ended SEP-786 on February 18 2025, which takes the model to USD20.89.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    15 min
  • QNT Stock Q2 2026: Quantinuum Earnings - The Bull Case Is Already The Price
    Quantinuum Inc (QNT) Q2 2026 — The results 8-K cleared EDGAR at 8:11pm ET on Monday August 11 - well AFTER the close, so Tuesday August 12 was the reaction session: the shares opened USD59.65 against a USD56.06 prior close, traded as high as USD72.40 and closed USD71.74. That is plus 27.97 pct on 4,584,200 shares, 3.45x the 20-session average, and it never traded back below Monday's close. By August 17 they were USD66.01.
    Quantinuum is the trapped-ion quantum computing company spun out of Honeywell. It priced its IPO at USD60.00 on June 5, 2026, so this is the FIRST quarter it has ever reported to a public market. Q2 revenue was USD7.998M, up 279.4 pct against a USD2.108M base quarter, with adjusted gross margin at 61.7 pct and USD2.107bn of cash against no debt. The shares rose 27.97 pct on the print.
    THE CALL: AVOID (3/5, MEDIUM - A REAL COMPANY, AT THE PRICE OF A CERTAINTY) — base-case value ~$26.56 vs ~$66.01 today.
    KEY METRICS:
    - CALL: AVOID, 3/5. Fair value USD26.56 against the USD66.01 close, minus 59.8 pct. Bear USD5.87 / base USD18.59 / bull USD65.71, weighted 30/45/25 across three 2030 revenue outcomes, each at a terminal sales multiple and discounted 4.5 years at 15 pct.
    - THE ANGLE: the bull case IS the price. Take the lowest target on the Street - Morgan Stanley's, at USD78 - and its own published model of 12x USD2.5bn of 2030 revenue. Discount that to TODAY instead of to 2027 and it is USD65.71 a share. The stock closed USD66.01.
    - WHAT THE PRICE ASSUMES: USD263.3M as-converted shares at USD66.01 is a USD17.38bn market value, less USD2.107bn of cash equals USD15.27bn of enterprise value. That is 509x the USD28-32M of revenue the company guides to for all of 2026.
    - THE SANITY CHECK: justifying today's enterprise value at 12x terminal sales needs USD2,387M of 2030 revenue - 164 pct growth a year for 4.5 years. BCG sizes the ENTIRE 2030 quantum provider market at USD1-2bn; BCC Research says USD7.3bn.
    - THE LOSS IS NOT WHAT IT LOOKS LIKE: GAAP net loss was USD596.520M, but USD464.587M is equity compensation vesting at the listing and USD47.615M is a non-cash warrant mark. 87.7 pct is non-cash or one-off. Adjusted EBITDA was minus USD68.310M.
    - THE COMP CUTS BOTH WAYS: revenue grew 279 pct off a USD2.108M trough, yet SIX-MONTH revenue FELL 37.6 pct, USD13.235M vs USD21.193M. Strip 2025's one-off USD16.526M lease sale and the recurring line is up 167 pct - that is the real number.
    - THE GUIDANCE NOBODY QUOTES: first formal guidance is USD28-32M, a USD30.0M midpoint against FY2025 revenue of USD30.931M. Flat to down on the total; roughly double the FY2025 recurring line of USD14.780M; and only 29 pct above FY2024's USD23.256M.
    What to watch: UP: a 2027 revenue range starting with a six or a seven rather than a three or a four, which moves the base case onto a different track entirely; or the Sol machine landing on schedule in 2027, which raises the odds on Apollo in 2029 where all the value sits. DOWN: contracted backlog converting slower than the 39.6 pct of USD74.2M the company schedules for the next twelve months, or any slip in the Apollo date.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    13 min
  • WRD Stock Q2 2026: WeRide Earnings - Revenue Doubled, The Loss Did Not
    WeRide Inc. (WRD) Q2 2026 — The results 6-K cleared EDGAR at 9:22am ET on August 12 - eight minutes BEFORE the open, so Wednesday August 12 was itself the reaction session: the shares opened USD6.27 against a USD6.33 prior close, were sold all day, traded as low as USD5.64, and closed USD5.72. That is minus 9.64 pct on 11,169,549 ADSs, 4.16x the 63-session average. By August 17 they were USD6.08.
    WeRide is a Guangzhou-based, Cayman-incorporated autonomous driving company listed on both Nasdaq and the Hong Kong exchange, and it calls itself the first publicly traded robotaxi company. It reports in renminbi under IFRS and files 6-K and 20-F, not 10-Q. Q2 2026 revenue rose 82.2 pct to RMB231.717M with gross margin at 37.5 pct - and the quarterly loss barely moved. The ADSs fell 9.64 pct on the print.
    THE CALL: HOLD (3/5, MEDIUM - REAL GROWTH, ALREADY IN THE PRICE) — base-case value ~$5.98 vs ~$6.08 today.
    KEY METRICS:
    - CALL: HOLD, 3/5. Fair value USD5.98 against the USD6.08 close, minus 1.6 pct. Bear USD3.25 / base USD6.10 / bull USD11.16, weighted 40/35/25 across 7.0x our 2027 revenue estimate, a 14 pct equity DCF that runs past the guided break-even, and 12x the 2026 revenue the Street models.
    - THE ANGLE: revenue rose 82.2 pct to RMB231.717M and gross profit rose 143.3 pct - and the loss for the period went RMB406.445M to RMB400.665M. It narrowed by RMB5.780M, or 1.4 pct. A full year of near-doubling revenue moved the bottom line by almost nothing.
    - WHY THE LOSS LOOKS FLAT: share-based compensation halved, RMB119.858M to RMB55.091M, and RMB64.270M of that RMB64.767M drop is in the administrative line alone - listing-related pay and global-offering fees rolling off. Non-cash and non-recurring. It is not operating leverage.
    - THE COMPANY'S OWN MEASURE GOT WORSE: non-IFRS adjusted loss, which strips exactly those items, went RMB300.558M to RMB338.453M. That is 12.6 pct WIDER year on year. Research alone was RMB434.329M - 1.87x total revenue - and it still grew 36.2 pct year on year.
    - THE ADS TRAP: one ADS is THREE Class A ordinary shares, not one, and the company reports in renminbi. Filed loss per ordinary share RMB0.41; per ADS RMB1.23, or USD0.18 at the company's own RMB6.7851 rate. Against a USD0.13149 bar that is a MISS of roughly 38 pct, not a beat.
    - THE VENDOR DATA IS DEFECTIVE: the Q2 feed row of minus USD0.18103 is per ADS, but the prior quarter's minus USD0.05507 is per ORDINARY SHARE - a threefold basis switch in adjacent rows. The filed quarters themselves foot: RMB114.140M plus RMB231.717M equals RMB345.857M.
    - THE CLOCK: cash, deposits and products fell RMB7,131.354M to RMB5,398.520M in six months - the company prints minus 24.3 pct itself - while also drawing RMB160.784M more bank debt. That is about 6.2 quarters of runway against a guided 2029 full-year break-even.
    What to watch: UP: the driver-assistance line reaching the 100,000 cumulative installations management targets for year end, against roughly 30,000 shipped in this quarter alone, or gross margin holding above 35 pct for another quarter. Either re-rates the sales multiple. DOWN: a quarterly cash draw that stays near RMB866M, which turns a funding question into a financing event well before the guided 2029 break-even.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    15 min
  • HAWK Stock Q2 2026: HawkEye 360 Earnings - The EPS Beat Was An IPO Artifact
    HawkEye 360 (HAWK) Q2 2026 — The 8-K cleared EDGAR at 4:05pm ET on August 13 - AFTER the close, so Friday August 14 was the reaction session: the shares opened minus 1.5 pct at USD24.00, fell as low as USD21.52 (minus 11.7 pct), and closed USD22.78, minus 6.52 pct, on 1.7M shares against a 1.29M average since listing.
    HawkEye 360 flies over 30 satellites that geolocate radio-frequency emitters and sells the intelligence to governments. It listed on the NYSE in May 2026, so this was only its second quarter public. Revenue was USD49.81M, up 87 pct, and the loss per share was USD0.07 against a USD0.1075 bar. But the press release and the 10-Q, filed on consecutive days, describe two different quarters.
    THE CALL: AVOID (3/5, MEDIUM - A REAL BUSINESS ON AN IPO-FLATTERED QUARTER) — base-case value ~$15.47 vs ~$23.16 today.
    KEY METRICS:
    - CALL: AVOID, 3/5. Fair value USD15.47 vs the USD23.16 close, minus 33.2 pct. Bear USD11.57 / base USD18.14 / bull USD25.55, weighted 40/35/25 across 5.0x 2028 consensus revenue, a discounted cash flow at 11.5 pct, and 20x 2028 consensus Adjusted EBITDA, on 97,965,552 shares.
    - THE EPS BRIDGE: the filed net loss was USD15.278M. A POSITIVE USD10.925M preferred stock dividend line - the reversal of accrued dividends when USD465.7M of preferred converted at the IPO - cut the loss to common to USD4.353M. Over 61,924,756 weighted shares that is USD0.07.
    - THE DENOMINATOR: 61,924,756 weighted shares against 97,960,719 actually outstanding on June 30, because the IPO closed May 8, mid-quarter. The same USD15.278M loss over the real share count is USD0.156. Next quarter the denominator has to rise 58.2 pct with no credit left.
    - THE GROWTH: revenue USD49.810M, up 87.1 pct as printed. But the 10-Q Note 3 pro forma restates Q2 2025 at USD41.632M including the December 2025 ISA acquisition - growth of 19.6 pct. Sequentially, USD49.798M became USD49.810M: plus 0.02 pct. International rose 0.8 pct QoQ.
    - THE BACKLOG: the release headlines USD292.2M of confirmed backlog, a management-defined term. The GAAP remaining performance obligation in the 10-Q is USD105.3M - and USD100.0M of that is ONE agreement to 2032 at USD5.0M a quarter starting Q2 2027. Next twelve months: USD8.291M.
    - THE CASH FLOW: free cash flow was plus USD5.389M on USD6.240M of cash capex. But gross satellites and equipment went USD199.215M to USD232.473M in the half - USD33.258M of additions on USD10.295M of cash capex. USD20.922M was a non-cash reclassification of prepaid deposits.
    - THE LOCK-UP: Item 8.01 of the same 8-K moved the release forward. The 180-day period ends November 2, inside a blackout, so the early-termination clause fires and 79.6M shares - 81 pct of the company - are free to trade September 2, against a float of 18.4M shares, or 18.8 pct.
    What to watch: UP: September-quarter revenue landing at the USD57.1M the Street already models, roughly 15 pct sequential growth, which puts HawkEye back on the full-year guidance path. Also a second sovereign award of the size already won. DOWN: a back half that misses the USD215-220M guide, into a float that quintuples on September 2 when the lock-up releases.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    15 min
  • HTHT Stock Q2 2026: H World Group Earnings - Fees Up 25 Pct, Same-Hotel RevPAR Down 3 Pct
    H World Group (HTHT) Q2 2026 — The 6-K cleared EDGAR at 6:30am ET on August 17, with the call at 7:00am - BEFORE the open, so August 17 was the reaction session itself: the ADSs opened plus 8.66 pct at USD45.51, ran to USD46.73, never traded below Friday's USD41.88 close, and finished plus 11.37 pct at USD46.64 on 2.2x volume.
    H World Group is the largest hotel operator in China - Hanting, JI, Orange, plus the Steigenberger brands abroad - with 13,539 hotels and 1,335,445 rooms at June 30. June-quarter revenue was RMB7,121m, up 10.8 pct, and adjusted earnings USD0.78 per ADS against a USD0.74 bar. But same-hotel RevPAR, for every China hotel open at least 18 months, FELL 3.0 pct to RMB233.
    THE CALL: BUY (3/5, MEDIUM - A FEE BUSINESS PRICED LIKE A HOTEL OWNER) — base-case value ~$55.38 vs ~$46.64 today.
    KEY METRICS:
    - CALL: BUY, 3/5. Fair value USD55.38 per ADS vs the USD46.64 close, plus 18.7 pct. Bear USD42.47 / base USD55.38 / bull USD72.18, weighted 50/30/20 across a ten-year cash flow discount at 12.0 pct, 11x 2026 adjusted EBITDA and 21x adjusted earnings, on 316.1M ADSs.
    - THE PRINT: revenue RMB7,121m, up 10.8 pct, about USD1,050m at the filing rate. Manachised and franchised fee revenue RMB3,586m, up 25.2 pct. Leased and owned revenue RMB3,233m, DOWN 4.9 pct by design. Operating margin 31.1 pct against 27.8 pct. Adjusted EBITDA RMB2,725m, up 20.0 pct.
    - THE EPS BASIS, PROVEN: the USD0.78 is ADJUSTED diluted per ADS, not GAAP. The filing prints RMB5.29, and 5.29 divided by the company's own RMB6.7851 rate is 0.7796. GAAP diluted was RMB4.87, or USD0.72 - a miss on that line. Q1 RMB3.36 plus Q2 RMB5.29 foots to the filed half of RMB8.65.
    - THE ANGLE: same-hotel RevPAR, every China hotel open at least 18 months, fell 3.0 pct to RMB233 from RMB240, on a flat room rate and occupancy down 2.4 points. The blended figure the release leads with rose 1.1 pct - but that blend includes hotels opened inside eighteen months.
    - WHY GAAP LOOKED FLAT: net income attributable rose only 2.1 pct to RMB1,577m and GAAP EPS per ADS was RMB4.87 against RMB4.85. One line explains it: currency gains were RMB366m a year ago and RMB49m this year, a RMB317m non-cash swing. Strip it and adjusted net income rose 26.9 pct.
    - THE GUIDANCE ARITHMETIC: full-year revenue growth was RAISED to 4-8 pct from 2-6 pct. But the first half already grew 11.0 pct. Against FY2025 revenue of RMB25,307m and a first half of RMB11,821m, that implies second-half growth of MINUS 2.1 pct to PLUS 5.4 pct - a raise embedding a slowdown.
    - THE BALANCE SHEET: RMB14,249m of cash against RMB4,226m of total debt - RMB10,165m of NET cash, about USD1,498m. A USD2.5bn three-year return plan was approved the same morning, and RMB2,844m of dividend plus RMB1,857m of buyback went out in the June quarter alone.
    What to watch: UP: same-hotel RevPAR turning positive through the September peak quarter, or a second-half revenue print above the top of the raised 4-8 pct guidance range. DOWN: the closure rate climbing above the 35 pct of gross openings it ran at this quarter, or overseas adjusted EBITDA falling further from RMB131m.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    15 min
  • FLY Stock Q2 2026: Firefly Aerospace Earnings - Record Revenue, $9.4M From Launch
    Firefly Aerospace (FLY) Q2 2026 — The 8-K cleared EDGAR at 4:08pm ET on August 11, AFTER the close, so Wednesday August 12 was the reaction session: the shares opened +1.33 pct at USD26.71, ran to USD27.74 (+5.24 pct), then gave it back and closed +0.68 pct at USD26.54 on 1.02x average volume. USD26.67 on August 14.
    Firefly Aerospace is a space and defense technology company that listed on the Nasdaq in August 2025. The June quarter set a revenue record: USD117.7M, up 657 pct, beating consensus by 33.4 pct, with non-GAAP loss per share of USD0.42 against a USD0.51 bar. But launch revenue inside that record was USD9.4M - 8.0 pct of the top line - and free cash burn was USD106.3M.
    THE CALL: AVOID (3/5, MEDIUM - A RECORD QUARTER THE ROCKETS BARELY JOINED) — base-case value ~$22.89 vs ~$26.67 today.
    KEY METRICS:
    - CALL: AVOID, 3/5. Fair value USD22.89 vs the USD26.67 close, -14.2 pct. Bear USD12.09 / base USD23.34 / bull USD44.27, weighted 50/30/20 across a scenario-weighted 2028 revenue multiple, 15x 2028 gross profit and 5.5x 2027 revenue, discounted at 13.0 pct to 180.0M shares.
    - THE PRINT: revenue USD117.7M vs USD88.2M expected, up 657 pct year on year and 45.5 pct sequentially - a 33.4 pct beat. Non-GAAP loss per share USD0.42 vs a USD0.51 bar, a USD0.09 beat. GAAP loss per share USD0.57. Adjusted EBITDA USD-61.2M against USD-47.9M a year earlier.
    - THE EPS BASIS, PROVEN BOTH WAYS: Q1 non-GAAP USD0.46 loss plus Q2 USD0.42 equals the filed six-month USD0.88, so the vendor epsActual series is non-GAAP. Q1 GAAP USD0.61 plus Q2 USD0.57 equals the filed USD1.18. The USD0.15 gap is the published bridge, USD24.6M exactly.
    - THE MIX, AND THE ANGLE: note 4 splits revenue two ways only. Launch revenue USD9.4M, up 48 pct - 8.0 pct of the record. Spacecraft Solutions USD108.3M, up 1,077 pct - and the 10-Q credits that to the inclusion of SciTec, acquired October 31 2025. Three customers are 72.1 pct of revenue.
    - THE MARGIN WENT BACKWARDS: gross margin 20.3 pct against 25.7 pct a year earlier, a fall of 541 basis points on revenue that grew more than sevenfold. Operating expense of USD119.1M is 101.2 pct of revenue. Stock compensation alone was USD17.0M, 14.5 pct of everything billed.
    - THE CASH CLOCK: free cash flow USD-106.3M in the quarter on the company's own reconciliation - USD81.6M operating burn plus USD24.7M capex. That is 90 cents out for every revenue dollar in. Cash and short-term investments USD635.3M, about 6.0 quarters, and liquidity still fell USD257.7M in the half after a USD181.6M June raise.
    - THE ORDER BOOK, AND WHAT IT IS WORTH: backlog USD1,468.1M at June 30, up 8.7 pct, book-to-bill 1.59x across the half. But remaining performance obligations are USD563.7M - only 38.4 pct of it - and USD403.1M is unscheduled multi-launch agreements. Enterprise value USD3,856M is 13.4x trailing revenue.
    What to watch: UP: a quarter where the launch line is a fifth of revenue rather than 8.0 pct, or gross margin recovering toward the 25.7 pct of a year ago, which is about USD6.4M a quarter of extra gross profit on this base. DOWN: free cash outflow holding above USD106.3M a quarter through Q4, which cuts runway under four quarters and forces a raise into weakness.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    15 min

About Charged Alpha Stock Encyclopedia

From the publisher's feed

⚡ Charged Alpha — The S&P 500 Stock Encyclopedia Data-driven deep dives into every stock in the S&P 500 after every earnings report. Each episode breaks down one company from open to close:…